Disclosure


PRESIDENT

Prof. David Araújo-Vilar, University of Santiago de Compostela, Spain

Prof. David Araujo Vilar has received honorary as board member, steering committee member, and/or speaker to Amryt Pharma, Regeneron, and  Third Rock Ventures.


VICE-PRESIDENT

Prof. Martin Wabitsch, University Medical Center Ulm, Germany



SECRETARY

Prof. Corinne Vigouroux, Sorbonne University, Paris, France



TREASURER

Prof. Ferrucio Santini, University of Pisa, Italy

Prof. Ferrucio Santini has worked as a consultant, participated in studies, and/or received travel funds from the following companies, which are involved with lipodystrophy and/or diabetes: AstraZeneca, Aegerion/Amryt, Novo Nordisk.


BOARD MEMBER

Prof. Elif Oral, University of Michigan, USA


BOARD MEMBER

Prof. Baris Akinci, Dokuz EylulUniversity School of Medicine, Izmir, Turkey

Dr. Akinci is a compensated consultant for Amryt Pharmaceuticals. Dr. Akinci serves as a consultant, add board member, steering committee member, and/or speaker to Regeneron, Third Rock Ventures, AstraZeneca, Novonordisk, Boehringer Ingelheim, Sanofi, Novartis, Bilim Ilac, ARIS, and Servier.